InvestorsHub Logo
Followers 82
Posts 12422
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Friday, 09/14/2018 12:58:54 PM

Friday, September 14, 2018 12:58:54 PM

Post# of 7180
• Allergan (AGN -1%) projects that its aesthetics business could double in six years according to Chief Commercial Officer Bill Meury. At its Medical Aesthetics Day in New York, he said the company expects the unit to generate $7B - 8B in sales by 2025 despite looming BOTOX competition from Revance Therapeutics (RVNC -3.3%) and Evolus (EOLS -2.3%). The business generated $3.8B in 2017.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News